Mitochondrial dysfunction and mitophagy defect triggered by heterozygous GBA mutations

References

• Sidransky E, Nalls MA, Aasly JO, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson’s disease. N Engl J Med. 2009;361(17):1651–1661.
   PubMed Web of Science ®Google Scholar
• Sidransky E, Lopez G. The link between the GBA gene and parkinsonism. Lancet Neurol. 2012;11(11):986–998.
   PubMed Web of Science ®Google Scholar
• Nalls MA, Duran R, Lopez G, et al. A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. JAMA Neurol. 2013;70(6):727–735.
   PubMed Web of Science ®Google Scholar
• Exner N, Lutz AK, Haass C, et al. Mitochondrial dysfunction in Parkinson’s disease: molecular mechanisms and pathophysiological consequences. EMBO J. 2012;31(14):3038–3062.
   PubMed Web of Science ®Google Scholar
• Schapira AH. Mitochondria in the aetiology and pathogenesis of Parkinson’s disease. Lancet Neurol. 2008;7(1):97–109.
   PubMed Web of Science ®Google Scholar
• Winklhofer KF, Haass C. Mitochondrial dysfunction in Parkinson’s disease. Biochim Biophys Acta. 2010;1802(1):29–44.
   PubMed Web of Science ®Google Scholar
• Ryan BJ, Hoek S, Fon EA, et al. Mitochondrial dysfunction and mitophagy in Parkinson’s: from familial to sporadic disease. Trends Biochem Sci. 2015;40(4):200–210.
   PubMed Web of Science ®Google Scholar
• Hamacher-Brady A, Brady NR. Mitophagy programs: mechanisms and physiological implications of mitochondrial targeting by autophagy. Cell Mol Life Sci. 2016;73(4):775–795.
   PubMed Web of Science ®Google Scholar
• Schapira AH, Chiasserini D, Beccari T, et al. Glucocerebrosidase in Parkinson’s disease: insights into pathogenesis and prospects for treatment. Mov Disord. 2016;31(6):830–835.
   PubMed Web of Science ®Google Scholar
• Osellame LD, Rahim AA, Hargreaves IP, et al. Mitochondria and quality control defects in a mouse model of Gaucher disease–links to Parkinson’s disease. Cell Metab. 2013;17(6):941–953.
   PubMed Web of Science ®Google Scholar
• Gegg ME, Schapira AH. Mitochondrial dysfunction associated with glucocerebrosidase deficiency. Neurobiol Dis. 2016;90:43–50.
   PubMed Web of Science ®Google Scholar
• Xu YH, Xu K, Sun Y, et al. Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice. Hum Mol Genet. 2014;23(15):3943–3957.
   PubMed Web of Science ®Google Scholar
• Sardi SP, Clarke J, Kinnecom C, et al. CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy. Proc Natl Acad Sci USA. 2011;108(29):12101–12106.
   PubMed Web of Science ®Google Scholar
• Taguchi YV, Liu J, Ruan J, et al. Glucosylsphingosine promotes α-synuclein pathology in mutant GBA-associated Parkinson’s Disease. J Neurosci. 2017;37(40):9617–9631.
   PubMed Web of Science ®Google Scholar
• Cilia R, Tunesi S, Marotta G, et al. Survival and dementia in GBA-associated Parkinson’s disease: the mutation matters. Ann Neurol. 2016;80(5):662–673.
   PubMed Web of Science ®Google Scholar
• Liu G, Boot B, Locascio JJ, et al. Specifically neuropathic Gaucher’s mutations accelerate cognitive decline in Parkinson’s. Ann Neurol. 2016;80(5):674–685.
   PubMed Web of Science ®Google Scholar
• Picard M, White K, Turnbull DM. Mitochondrial morphology, topology, and membrane interactions in skeletal muscle: a quantitative three-dimensional electron microscopy study. J Appl Physiol (1985). 2013;114(2):161–171.
   PubMed Web of Science ®Google Scholar
• Tang G, Gutierrez Rios P, Kuo SH, et al. Mitochondrial abnormalities in temporal lobe of autistic brain. Neurobiol Dis. 2013;54:349–361.
   PubMed Web of Science ®Google Scholar
• Medeiros DM. Assessing mitochondria biogenesis. Methods. 2008;46(4):288–294.
   PubMed Web of Science ®Google Scholar
• Itoh K, Nakamura K, Iijima M, et al. Mitochondrial dynamics in neurodegeneration. Trends Cell Biol. 2013;23(2):64–71.
   PubMed Web of Science ®Google Scholar
• van der Bliek AM, Shen Q, Kawajiri S. Mechanisms of mitochondrial fission and fusion. Cold Spring Harb Perspect Biol. 2013;5(6):pii:a011072.
   PubMed Web of Science ®Google Scholar
• Sun N, Yun J, Liu J, et al. Measuring In Vivo Mitophagy. Mol Cell. 2015;60(4):685–696.
   PubMed Web of Science ®Google Scholar
• Katayama H, Kogure T, Mizushima N, et al. A sensitive and quantitative technique for detecting autophagic events based on lysosomal delivery. Chem Biol. 2011;18(8):1042–1052.
   PubMedGoogle Scholar
• Sargsyan A, Cai J, Fandino LB, et al. Rapid parallel measurements of macroautophagy and mitophagy in mammalian cells using a single fluorescent biosensor. Sci Rep. 2015;5:12397.
   PubMed Web of Science ®Google Scholar
• Cai Q, Zakaria HM, Simone A, et al. Spatial parkin translocation and degradation of damaged mitochondria via mitophagy in live cortical neurons. Curr Biol. 2012;22(6):545–552.
   PubMed Web of Science ®Google Scholar
• Durcan TM, Fon EA. The three ‘P’s of mitophagy: PARKIN, PINK1, and post-translational modifications. Genes Dev. 2015;29(10):989–999.
   PubMed Web of Science ®Google Scholar
• Ebrahimi-Fakhari D, Saffari A, Wahlster L, et al. Impaired mitochondrial dynamics and mitophagy in neuronal models of tuberous sclerosis complex. Cell Rep. 2016;17(4):1053–1070.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Enriquez S, Kim I, Currin RT, et al. Tracker dyes to probe mitochondrial autophagy (mitophagy) in rat hepatocytes. Autophagy. 2006;2(1):39–46.
   PubMed Web of Science ®Google Scholar
• Zhu J, Dagda RK, Chu CT. Monitoring mitophagy in neuronal cell cultures. Methods Mol Biol. 2011;793:325–339.
   PubMedGoogle Scholar
• Youle RJ, Narendra DP. Mechanisms of mitophagy. Nat Rev Mol Cell Biol. 2011;12(1):9–14.
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abdelmohsen K, Abe A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016;12(1):1–222.
   PubMed Web of Science ®Google Scholar
• Nazio F, Cecconi F. mTOR, AMBRA1, and autophagy: an intricate relationship. Cell Cycle. 2013;12(16):2524–2525.
   PubMed Web of Science ®Google Scholar
• Strappazzon F, Vietri-Rudan M, Campello S, et al. Mitochondrial BCL-2 inhibits AMBRA1-induced autophagy. EMBO J. 2011;30(7):1195–1208.
   PubMed Web of Science ®Google Scholar
• Li L, Wang ZV, Hill JA, et al. New autophagy reporter mice reveal dynamics of proximal tubular autophagy. J Am Soc Nephrol. 2014;25(2):305–315.
   PubMed Web of Science ®Google Scholar
• Kimura S, Noda T, Yoshimori T. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy. 2007;3(5):452–460.
   PubMed Web of Science ®Google Scholar
• Ni HM, Bockus A, Wozniak AL, et al. Dissecting the dynamic turnover of GFP-LC3 in the autolysosome. Autophagy. 2011;7(2):188–204.
   PubMed Web of Science ®Google Scholar
• Ron I, Horowitz M. ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity. Hum Mol Genet. 2005;14(16):2387–2398.
   PubMed Web of Science ®Google Scholar
• Cleeter MW, Chau KY, Gluck C, et al. Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage. Neurochem Int. 2013;62(1):1–7.
   PubMed Web of Science ®Google Scholar
• de la Mata M, Cotán D, Oropesa-Ávila M, et al. Pharmacological chaperones and coenzyme Q10 treatment improves mutant β-glucocerebrosidase activity and mitochondrial function in neuronopathic forms of gaucher disease. Sci Rep. 2015;5:10903.
   PubMed Web of Science ®Google Scholar
• Jin SM, Youle RJ. PINK1- and Parkin-mediated mitophagy at a glance. J Cell Sci. 2012;125(Pt 4):795–799.
   PubMed Web of Science ®Google Scholar
• Novak I. Mitophagy: a complex mechanism of mitochondrial removal. Antioxid Redox Signal. 2012;17(5):794–802.
   PubMed Web of Science ®Google Scholar
• Berthet A, Margolis EB, Zhang J, et al. Loss of mitochondrial fission depletes axonal mitochondria in midbrain dopamine neurons. J Neurosci. 2014;34(43):14304–14317.
   PubMed Web of Science ®Google Scholar
• Poole AC, Thomas RE, Andrews LA, et al. The PINK1/Parkin pathway regulates mitochondrial morphology. Proc Natl Acad Sci USA. 2008;105(5):1638–1643.
   PubMed Web of Science ®Google Scholar
• Wang X, Petrie TG, Liu Y, et al. Parkinson’s disease-associated DJ-1 mutations impair mitochondrial dynamics and cause mitochondrial dysfunction. J Neurochem. 2012;121(5):830–839.
   PubMed Web of Science ®Google Scholar
• Wang X, Yan MH, Fujioka H, et al. LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1. Hum Mol Genet. 2012;21(9):1931–1944.
   PubMed Web of Science ®Google Scholar
• Kamp F, Exner N, Lutz AK, et al. Inhibition of mitochondrial fusion by α-synuclein is rescued by PINK1, Parkin and DJ-1. EMBO J. 2010;29(20):3571–3589.
   PubMed Web of Science ®Google Scholar
• Loson OC, Song Z, Chen H, et al. Fis1, Mff, MiD49, and MiD51 mediate Drp1 recruitment in mitochondrial fission. Mol Biol Cell. 2013;24(5):659–667.
   PubMed Web of Science ®Google Scholar
• Twig G, Elorza A, Molina AJ, et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J. 2008;27(2):433–446.
   PubMed Web of Science ®Google Scholar
• Magalhaes J, Gegg ME, Migdalska-Richards A, et al. Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson disease. Hum Mol Genet. 2016;25(16):3432–3445.
   PubMed Web of Science ®Google Scholar
• Kinghorn KJ, Grönke S, Castillo-Quan JI, et al. A drosophila model of neuronopathic gaucher disease demonstrates lysosomal-autophagic defects and altered mTOR signalling and is functionally rescued by rapamycin. J Neurosci. 2016;36(46):11654–11670.
   PubMed Web of Science ®Google Scholar
• Awad O, Sarkar C, Panicker LM, et al. Altered TFEB-mediated lysosomal biogenesis in Gaucher disease iPSC-derived neuronal cells. Hum Mol Genet. 2015;24(20):5775–5788.
   PubMed Web of Science ®Google Scholar
• Narendra D, Walker JE, Youle R. Mitochondrial quality control mediated by PINK1 and Parkin: links to parkinsonism. Cold Spring Harb Perspect Biol. 2012;4(11):pii: a011338.
   PubMed Web of Science ®Google Scholar
• Ni HM, Williams JA, Ding WX. Mitochondrial dynamics and mitochondrial quality control. Redox Biol. 2015;4:6–13.
   PubMed Web of Science ®Google Scholar
• Narendra D, Tanaka A, Suen DF, et al. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol. 2008;183(5):795–803.
   PubMed Web of Science ®Google Scholar
• Richter B, Sliter DA, Herhaus L, et al. Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy of damaged mitochondria. Proc Natl Acad Sci USA. 2016;113(15):4039–4044.
   PubMed Web of Science ®Google Scholar
• Lazarou M, Sliter DA, Kane LA, et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature. 2015;524(7565):309–314.
   PubMed Web of Science ®Google Scholar
• Wong YC, Holzbaur EL. Temporal dynamics of PARK2/parkin and OPTN/optineurin recruitment during the mitophagy of damaged mitochondria. Autophagy. 2015;11(2):422–424.
   PubMed Web of Science ®Google Scholar
• Pankiv S, Clausen TH, Lamark T, et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem. 2007;282(33):24131–24145.
   PubMed Web of Science ®Google Scholar
• Thurston TL, Ryzhakov G, Bloor S, et al. The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria. Nat Immunol. 2009;10(11):1215–1221.
   PubMed Web of Science ®Google Scholar
• Kirkin V, Lamark T, Sou Y-S, et al. A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. Mol Cell. 2009;33(4):505–516.
   PubMed Web of Science ®Google Scholar
• Schweers RL, Zhang J, Randall MS, et al. NIX is required for programmed mitochondrial clearance during reticulocyte maturation. Proc Natl Acad Sci USA. 2007;104(49):19500–19505.
   PubMed Web of Science ®Google Scholar
• Novak I, Kirkin V, McEwan DG, et al. Nix is a selective autophagy receptor for mitochondrial clearance. EMBO Rep. 2010;11(1):45–51.
   PubMed Web of Science ®Google Scholar
• Liu L, Feng D, Chen G, et al. Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat Cell Biol. 2012;14(2):177–185.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Massen S, Terenzio M, et al. Modulation of serines 17 and 24 in the LC3-interacting region of Bnip3 determines pro-survival mitophagy versus apoptosis. J Biol Chem. 2013;288(2):1099–1113.
   PubMed Web of Science ®Google Scholar
• Van Humbeeck C, Cornelissen T, Hofkens H, et al. Parkin interacts with Ambra1 to induce mitophagy. J Neurosci. 2011;31(28):10249–10261.
   PubMed Web of Science ®Google Scholar
• Strappazzon F, Nazio F, Corrado M, et al. AMBRA1 is able to induce mitophagy via LC3 binding, regardless of PARKIN and p62/SQSTM1. Cell Death Differ. 2015;22(3):419–432.
   PubMed Web of Science ®Google Scholar
• Bendikov-Bar I, Ron I, Filocamo M, et al. Characterization of the ERAD process of the L444P mutant glucocerebrosidase variant. Blood Cells Mol Dis. 2011;46(1):4–10.
   PubMed Web of Science ®Google Scholar
• Bendikov-Bar I, Horowitz M. Gaucher disease paradigm: from ERAD to comorbidity. Hum Mutat. 2012;33(10):1398–1407.
   PubMed Web of Science ®Google Scholar
• Ron I, Rapaport D, Horowitz M. Interaction between parkin and mutant glucocerebrosidase variants: a possible link between Parkinson disease and Gaucher disease. Hum Mol Genet. 2010;19(19):3771–3781.
   PubMed Web of Science ®Google Scholar
• Bendikov-Bar I, Rapaport D, Larisch S, et al. Parkin-mediated ubiquitination of mutant glucocerebrosidase leads to competition with its substrates PARIS and ARTS. Orphanet J Rare Dis. 2014;9:86.
   PubMed Web of Science ®Google Scholar
• Mazzulli JR, Xu YH, Sun Y, et al. Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell. 2011;146(1):37–52.
   PubMed Web of Science ®Google Scholar
• Mullin S, Schapira A. α-Synuclein and mitochondrial dysfunction in Parkinson’s disease. Mol Neurobiol. 2013;47(2):587–597.
   PubMed Web of Science ®Google Scholar
• Zaltieri M, Longhena F, Pizzi M, et al. Mitochondrial dysfunction and α-synuclein synaptic pathology in parkinson’s disease: who’s on first? Parkinsons Dis. 2015;2015:108029.
   PubMedGoogle Scholar
• McNeill A, Magalhaes J, Shen C, et al. Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells. Brain. 2014;137(Pt 5):1481–1495.
   PubMed Web of Science ®Google Scholar
• Kim YC, Park HW, Sciarretta S, et al. Rag GTPases are cardioprotective by regulating lysosomal function. Nat Commun. 2014;5:4241.
   PubMed Web of Science ®Google Scholar
• Schreiner B, Ankarcrona M. Isolation of Mitochondria-Associated Membranes (MAM) from mouse brain tissue. Methods Mol Biol. 2017;1567:53–68.
   PubMedGoogle Scholar
• Aras MA, Hartnett KA, Aizenman E. Assessment of cell viability in primary neuronal cultures. Curr Protoc Neurosci. 2008;44:7.18.1–7.18.5.
   Google Scholar
• Rockenstein E, Nuber S, Overk CR, et al. Accumulation of oligomer-prone alpha-synuclein exacerbates synaptic and neuronal degeneration in vivo. Brain. 2014;137(1):1496–1513.
   PubMedGoogle Scholar
• Gegg ME, Burke D, Heales SJ, et al. Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains. Ann Neurol. 2012;72(3):455–463.
   PubMed Web of Science ®Google Scholar